drugset / Trial / NCT00003454

Antineoplaston Therapy in Treating Women With Stage IV Breast Cancer

NCT00003454

Phase 2 Terminated 19 enrolled Burzynski Research Institute
NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Antineoplastons are naturally-occurring substances that may also be made in the laboratory. Antineoplastons may inhibit the growth of cancer cells. PURPOSE: This phase II trial studies the effectiveness of antineoplaston therapy in treating women who have stage IV breast cancer that has not responded to previous therapy.

Timeline

Start
1996-03-18
Primary completion
2002-12-28
Completion
2002-12-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Astugenal Unknown Intravenous
Subject antineoplaston A10 Small molecule Intravenous